772.569.5309

Fax

Vero Beach - 2750 Indian River Blvd
Sebastian - 13397 U.S. 1

Florida Eye Institute Blog

Essential Sight Saving Treatments in the Midst of COVID Crisis

Patients with sight limiting diseases like Macular Degeneration know the importance of regular treatments to preserve existing vision. The most common treatments to slow vision loss from wet macular degeneration are anti-VEGF intravitreal injections. These drugs are considered the first-line treatment for all stages of wet macular degeneration and are typically scheduled every 4-6 weeks to maintain effectiveness. That all changed in the past month with the outbreak of COVID-19. Both the American Academy of Ophthalmology and CDC have advised limited medical office visits to minimize risk and exposure to the novel coronavirus for patients and staff. To accommodate the situation, Florida Eye Institute quickly prioritized procedures to continue providing care for their most vulnerable patient populations.

Read More »

Florida Eye Institute Hosts

Learn about the latest trends in ophthalmology during the Meet the Doctor seminar series at Florida Eye Institute. Enjoy a light lunch and discover how laser advancements and surgical options can improve vision like never before. All seminars are FREE and open to the public. Friday, Feb. 28, 2020: NEW! FDA Approved BEOVU for Macular Degeneration. Thomas Baudo, MD, Board Certified Ophthalmology Learn about the latest treatment in the fight against wet macular degeneration, the leading cause of severe and irreversible vision loss for adults over 65. Friday, March 6, 2020: Glaucoma Update 2020

Read More »

NEW! FDA Treatment BEOVU for Wet Macular Degeneration

The Macular Degeneration and Diabetes Center of Florida Eye Institute offers the latest FDA approved Beovu injection for patients with wet macular degeneration. Wet AMD is the leading cause of severe vision loss and legal blindness for people over the age of 65. It

Read More »

Florida Eye Institute Surgeons Certified in New Hydrus Microstent for Glaucoma

Florida Eye Institute cataract surgeon Karen Todd, MD has successfully demonstrated the technical knowledge to implant the Hydrus Microstent according to certification by Richard Hope, MD, Vice President of Clinical and Medical Affairs at Ivantis. Hydrus is the latest FDA approved minimally invasive glaucoma surgery (MIGS) device used for the treatment of mild to moderate primary open-angle glaucoma in conjunction with cataract surgery.

Read More »

Three Things to Know about Cataracts

Approximately 25 million Americans have cataracts, which causes cloudy, blurry or dim vision and typically develops with age. Florida Eye Institute joins the American Academy of Ophthalmology this June in observing Cataract Awareness Month with three things you should know about the condition and its treatment. As we grow older, the lens of the eye thickens and becomes cloudy. Colors may seem dull and street signs more difficult to read. These common symptoms can signal the onset of cataract, which affects 70 percent of people by age 75. Fortunately, the condition can easily be corrected. Ophthalmologists in the US perform around three million cataract surgeries each year to restore vision. Here are three important facts to know about the onset of cataract and treatment. Age isn

Read More »

Request Appointment

Fill out the form below, and we will be in touch shortly.
Are you a new or returning patient?
Contact Information
Sex